These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29718126)

  • 1. Relapse pathway of glioblastoma revealed by single-cell molecular analysis.
    Chen X; Wen Q; Stucky A; Zeng Y; Gao S; Loudon WG; Ho HW; Kabeer MH; Li SC; Zhang X; Zhong JF
    Carcinogenesis; 2018 Jul; 39(7):931-936. PubMed ID: 29718126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Zooming in" on Glioblastoma: Understanding Tumor Heterogeneity and its Clinical Implications in the Era of Single-Cell Ribonucleic Acid Sequencing.
    Khalafallah AM; Huq S; Jimenez AE; Serra R; Bettegowda C; Mukherjee D
    Neurosurgery; 2021 Feb; 88(3):477-486. PubMed ID: 32674143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of MicroRNAs in patients with glioblastoma after concomitant chemoradiotherapy.
    Park EC; Kim G; Jung J; Wang K; Lee S; Jeon SS; Lee ZW; Kim SI; Kim S; Oh YT; Shin JH; Jang HS; Choi BO; Kim GH
    OMICS; 2013 May; 17(5):259-68. PubMed ID: 23586679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival kinase genes present prognostic significance in glioblastoma.
    Varghese RT; Liang Y; Guan T; Franck CT; Kelly DF; Sheng Z
    Oncotarget; 2016 Apr; 7(15):20140-51. PubMed ID: 26956052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive genetic alteration profiling in primary and recurrent glioblastoma.
    Neilsen BK; Sleightholm R; McComb R; Ramkissoon SH; Ross JS; Corona RJ; Miller VA; Cooke M; Aizenberg MR
    J Neurooncol; 2019 Mar; 142(1):111-118. PubMed ID: 30535594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognizing and correcting failures in glioblastoma treatment.
    Shah AH; Graham R; Bregy A; Thambuswamy M; Komotar RJ
    Cancer Invest; 2014 Jul; 32(6):299-302. PubMed ID: 24766304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decoding key cell sub-populations and molecular alterations in glioblastoma at recurrence by single-cell analysis.
    Wang X; Sun Q; Wang W; Liu B; Gu Y; Chen L
    Acta Neuropathol Commun; 2023 Jul; 11(1):125. PubMed ID: 37525259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution.
    Kim H; Zheng S; Amini SS; Virk SM; Mikkelsen T; Brat DJ; Grimsby J; Sougnez C; Muller F; Hu J; Sloan AE; Cohen ML; Van Meir EG; Scarpace L; Laird PW; Weinstein JN; Lander ES; Gabriel S; Getz G; Meyerson M; Chin L; Barnholtz-Sloan JS; Verhaak RG
    Genome Res; 2015 Mar; 25(3):316-27. PubMed ID: 25650244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive molecular characterization of multifocal glioblastoma proves its monoclonal origin and reveals novel insights into clonal evolution and heterogeneity of glioblastomas.
    Abou-El-Ardat K; Seifert M; Becker K; Eisenreich S; Lehmann M; Hackmann K; Rump A; Meijer G; Carvalho B; Temme A; Schackert G; Schröck E; Krex D; Klink B
    Neuro Oncol; 2017 Apr; 19(4):546-557. PubMed ID: 28201779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tracking intratumoral heterogeneity in glioblastoma via regularized classification of single-cell RNA-Seq data.
    Lopes MB; Vinga S
    BMC Bioinformatics; 2020 Feb; 21(1):59. PubMed ID: 32070274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intra- and inter-tumoral heterogeneity on molecular characteristics of primary IDH-wild type glioblastoma revealed by single-cell analysis.
    Xiong Z; Yang Q; Li X
    CNS Neurosci Ther; 2020 Sep; 26(9):981-989. PubMed ID: 32488994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multilayered Heterogeneity of Glioblastoma Stem Cells: Biological and Clinical Significance.
    Brown DV; Stylli SS; Kaye AH; Mantamadiotis T
    Adv Exp Med Biol; 2019; 1139():1-21. PubMed ID: 31134492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-cell atlas reveals the immunosuppressive microenvironment and Treg cells landscapes in recurrent Glioblastoma.
    Wang X; Ge Y; Hou Y; Wang X; Yan Z; Li Y; Dong L; She L; Tang C; Wei M; Zhang H
    Cancer Gene Ther; 2024 May; 31(5):790-801. PubMed ID: 38429367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-Cell RNA-Seq Analysis of Infiltrating Neoplastic Cells at the Migrating Front of Human Glioblastoma.
    Darmanis S; Sloan SA; Croote D; Mignardi M; Chernikova S; Samghababi P; Zhang Y; Neff N; Kowarsky M; Caneda C; Li G; Chang SD; Connolly ID; Li Y; Barres BA; Gephart MH; Quake SR
    Cell Rep; 2017 Oct; 21(5):1399-1410. PubMed ID: 29091775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative Clinical Imaging Methods for Monitoring Intratumoral Evolution.
    Kim JY; Gatenby RA
    Methods Mol Biol; 2017; 1513():61-81. PubMed ID: 27807831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing mutational heterogeneity in a glioblastoma patient with double recurrence.
    Nickel GC; Barnholtz-Sloan J; Gould MP; McMahon S; Cohen A; Adams MD; Guda K; Cohen M; Sloan AE; LaFramboise T
    PLoS One; 2012; 7(4):e35262. PubMed ID: 22536362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High mobility group A1 expression shows negative correlation with recurrence time in patients with glioblastoma multiforme.
    Liu B; Pang B; Liu H; Arakawa Y; Zhang R; Feng B; Zhong P; Murata D; Fan H; Xin T; Zhao G; Liu W; Guo H; Luan L; Xu S; Miyamoto S; Pang Q
    Pathol Res Pract; 2015 Aug; 211(8):596-600. PubMed ID: 26092597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and evolution of double minutes in diagnosis and relapse brain tumors.
    Xu K; Ding L; Chang TC; Shao Y; Chiang J; Mulder H; Wang S; Shaw TI; Wen J; Hover L; McLeod C; Wang YD; Easton J; Rusch M; Dalton J; Downing JR; Ellison DW; Zhang J; Baker SJ; Wu G
    Acta Neuropathol; 2019 Jan; 137(1):123-137. PubMed ID: 30267146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatiotemporal genomic architecture informs precision oncology in glioblastoma.
    Lee JK; Wang J; Sa JK; Ladewig E; Lee HO; Lee IH; Kang HJ; Rosenbloom DS; Camara PG; Liu Z; van Nieuwenhuizen P; Jung SW; Choi SW; Kim J; Chen A; Kim KT; Shin S; Seo YJ; Oh JM; Shin YJ; Park CK; Kong DS; Seol HJ; Blumberg A; Lee JI; Iavarone A; Park WY; Rabadan R; Nam DH
    Nat Genet; 2017 Apr; 49(4):594-599. PubMed ID: 28263318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial analysis of recurrent glioblastoma reveals perivascular niche organization.
    Onubogu U; Gatenbee CD; Prabhakaran S; Wolfe KL; Oakes B; Salatino R; Vaubel R; Szentirmai O; Anderson AR; Janiszewska M
    JCI Insight; 2024 May; 9(12):. PubMed ID: 38805346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.